Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 143

1.

Adaptive response in the antioxidant defence system in the course and outcome in first-episode schizophrenia patients: a 12-months follow-up study.

Ruiz-Litago F, Seco J, Echevarría E, Martínez-Cengotitabengoa M, Gil J, Irazusta J, González-Pinto AM.

Psychiatry Res. 2012 Dec 30;200(2-3):218-22. doi: 10.1016/j.psychres.2012.07.024. Epub 2012 Aug 9.

PMID:
22884309
2.

Changes in oxidative stress markers in patients with schizophrenia: the effect of antipsychotic drugs.

Tsai MC, Liou CW, Lin TK, Lin IM, Huang TL.

Psychiatry Res. 2013 Oct 30;209(3):284-90. doi: 10.1016/j.psychres.2013.01.023. Epub 2013 Mar 14.

PMID:
23497820
3.

Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia.

Puertas MC, Martínez-Martos JM, Cobo MP, Carrera MP, Mayas MD, Ramírez-Expósito MJ.

Exp Gerontol. 2012 Aug;47(8):625-30. doi: 10.1016/j.exger.2012.05.019. Epub 2012 Jun 1.

PMID:
22664577
4.

Carotid artery intima-media thickness correlates with oxidative stress in chronic haemodialysis patients with accelerated atherosclerosis.

Dursun B, Dursun E, Suleymanlar G, Ozben B, Capraz I, Apaydin A, Ozben T.

Nephrol Dial Transplant. 2008 May;23(5):1697-703. doi: 10.1093/ndt/gfm906. Epub 2008 Jan 3.

5.

The effect of hemodialysis on accelerated atherosclerosis in diabetic patients: correlation of carotid artery intima-media thickness with oxidative stress.

Dursun B, Dursun E, Suleymanlar G, Ozben B, Capraz I, Apaydin A, Ozben T.

J Diabetes Complications. 2009 Jul-Aug;23(4):257-64. doi: 10.1016/j.jdiacomp.2007.12.007. Epub 2008 Apr 16.

PMID:
18413174
6.

Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients.

Raffa M, Atig F, Mhalla A, Kerkeni A, Mechri A.

BMC Psychiatry. 2011 Aug 2;11:124. doi: 10.1186/1471-244X-11-124.

7.

Plasma TBARS, blood GSH concentrations, and erythrocyte antioxidant enzyme activities in regularly menstruating women with ovulatory and anovulatory menstrual cycles.

Lutosławska G, Tkaczyk J, Panczenko-Kresowska B, Hübner-Woźniak E, Skierska E, Gajewski AK.

Clin Chim Acta. 2003 May;331(1-2):159-63.

PMID:
12691877
8.
9.

Decreased glutathione levels and antioxidant enzyme activities in untreated and treated schizophrenic patients.

Raffa M, Mechri A, Othman LB, Fendri C, Gaha L, Kerkeni A.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Oct 1;33(7):1178-83. doi: 10.1016/j.pnpbp.2009.06.018. Epub 2009 Jul 2.

PMID:
19576938
10.

Ameliorative potential of S-allyl cysteine on oxidative stress in STZ induced diabetic rats.

Saravanan G, Ponmurugan P.

Chem Biol Interact. 2011 Jan 15;189(1-2):100-6. doi: 10.1016/j.cbi.2010.10.001. Epub 2010 Oct 14.

PMID:
20951120
11.

Reduced antioxidant defense in early onset first-episode psychosis: a case-control study.

Micó JA, Rojas-Corrales MO, Gibert-Rahola J, Parellada M, Moreno D, Fraguas D, Graell M, Gil J, Irazusta J, Castro-Fornieles J, Soutullo C, Arango C, Otero S, Navarro A, Baeza I, Martínez-Cengotitabengoa M, González-Pinto A.

BMC Psychiatry. 2011 Feb 14;11:26. doi: 10.1186/1471-244X-11-26.

12.

Peripheral parameters of oxidative stress in Graves' disease: the effects of methimazole and 131 iodine treatments.

Abalovich M, Llesuy S, Gutierrez S, Repetto M.

Clin Endocrinol (Oxf). 2003 Sep;59(3):321-7.

PMID:
12919155
13.

The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance.

Akyol O, Herken H, Uz E, Fadillioğlu E, Unal S, Söğüt S, Ozyurt H, Savaş HA.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Jun;26(5):995-1005.

PMID:
12369276
14.

Blood oxidative stress markers in Gaucher disease patients.

Roversi FM, Galdieri LC, Grego BH, Souza FG, Micheletti C, Martins AM, D'Almeida V.

Clin Chim Acta. 2006 Feb;364(1-2):316-20. Epub 2005 Aug 24.

PMID:
16125160
16.
17.

Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.

Kesavulu MM, Giri R, Kameswara Rao B, Apparao C.

Diabetes Metab. 2000 Nov;26(5):387-92.

18.

Altered antioxidant defense system in clinically stable patients with schizophrenia and their unaffected siblings.

Ben Othmen L, Mechri A, Fendri C, Bost M, Chazot G, Gaha L, Kerkeni A.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):155-9. Epub 2007 Aug 14.

PMID:
17804133
19.

Nitrite content and antioxidant enzyme levels in the blood of schizophrenia patients.

Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Srimal RC, Seth PK, Dikshit M.

Psychopharmacology (Berl). 2001 Nov;158(2):140-5.

PMID:
11702087
20.

Hyperglycemia induced oxidative stress in type-1 and type-2 diabetic patients with and without nephropathy.

Dave GS, Kalia K.

Cell Mol Biol (Noisy-le-grand). 2007 May 30;53(5):68-78.

PMID:
17543235
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk